These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 8317948

  • 1. Effects of metabolic perturbation on plasma homovanillic acid in schizophrenia. Relationship to prefrontal cortex volume.
    Breier A, Davis OR, Buchanan RW, Moricle LA, Munson RC.
    Arch Gen Psychiatry; 1993 Jul; 50(7):541-50. PubMed ID: 8317948
    [Abstract] [Full Text] [Related]

  • 2. A.E. Bennett award paper. Experimental approaches to human stress research: assessment of neurobiological mechanisms of stress in volunteers and psychiatric patients.
    Breier A.
    Biol Psychiatry; 1989 Sep; 26(5):438-62. PubMed ID: 2551397
    [Abstract] [Full Text] [Related]

  • 3. Evidence that brain tissue volumes are associated with HVA reactivity to metabolic stress in schizophrenia.
    Marcelis M, Suckling J, Hofman P, Woodruff P, Bullmore E, van Os J.
    Schizophr Res; 2006 Sep; 86(1-3):45-53. PubMed ID: 16806836
    [Abstract] [Full Text] [Related]

  • 4. Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizophrenia, their unaffected siblings and controls.
    Brunelin J, d'Amato T, van Os J, Cochet A, Suaud-Chagny MF, Saoud M.
    Schizophr Res; 2008 Mar; 100(1-3):206-11. PubMed ID: 18155448
    [Abstract] [Full Text] [Related]

  • 5. Abnormal response to metabolic stress in schizophrenia: marker of vulnerability or acquired sensitization?
    Marcelis M, Cavalier E, Gielen J, Delespaul P, Van Os J.
    Psychol Med; 2004 Aug; 34(6):1103-11. PubMed ID: 15554580
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment.
    Pickar D, Labarca R, Doran AR, Wolkowitz OM, Roy A, Breier A, Linnoila M, Paul SM.
    Arch Gen Psychiatry; 1986 Jul; 43(7):669-76. PubMed ID: 3718170
    [Abstract] [Full Text] [Related]

  • 8. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
    Davidson M, Kahn RS, Powchik P, Warne P, Losonczy MF, Kaminsky R, Apter S, Jaff S, Davis KL.
    Arch Gen Psychiatry; 1991 Jan; 48(1):73-6. PubMed ID: 1670618
    [Abstract] [Full Text] [Related]

  • 9. Effects of acute metabolic stress on the peripheral vasopressinergic system in schizophrenia.
    Elman I, Lukas S, Shoaf SE, Rott D, Adler C, Breier A.
    J Psychopharmacol; 2003 Sep; 17(3):317-23. PubMed ID: 14513924
    [Abstract] [Full Text] [Related]

  • 10. Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics.
    Duncan E, Wolkin A, Angrist B, Sanfilipo M, Wieland S, Cooper TB, Rotrosen J.
    Biol Psychiatry; 1993 Oct 15; 34(8):523-8. PubMed ID: 8274579
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
    Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB, Charney DS.
    Arch Gen Psychiatry; 1994 Mar 15; 51(3):199-214. PubMed ID: 8122957
    [Abstract] [Full Text] [Related]

  • 14. A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls.
    Davidson M, Davis KL.
    Arch Gen Psychiatry; 1988 Jun 15; 45(6):561-3. PubMed ID: 3377642
    [Abstract] [Full Text] [Related]

  • 15. Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations.
    Davidson M, Kahn RS, Knott P, Kaminsky R, Cooper M, DuMont K, Apter S, Davis KL.
    Arch Gen Psychiatry; 1991 Oct 15; 48(10):910-3. PubMed ID: 1929760
    [Abstract] [Full Text] [Related]

  • 16. Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics.
    Kim YK, Kim L, Lee MS.
    Schizophr Res; 2000 Sep 01; 44(3):165-75. PubMed ID: 10962218
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological effects of methylphenidate on plasma homovanillic acid and growth hormone.
    Sharma RP, Javaid JI, Pandey GN, Easton M, Davis JM.
    Psychiatry Res; 1990 Apr 01; 32(1):9-17. PubMed ID: 2190251
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.
    Kahn RS, Davidson M, Knott P, Stern RG, Apter S, Davis KL.
    Arch Gen Psychiatry; 1993 Aug 01; 50(8):599-605. PubMed ID: 7688208
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.